Synthetic Compound
What is Coluracetam Coluracetam belongs to the racetam family of nootropic compounds. Originally synthesized by Mitsubishi Tanabe Pharma Corporation in Japan (circa mid-2000s), it was developed as a potential treatment for Alzheimer’s disease. Following unsuccessful efficacy trials, the compound was in-licensed by BrainCells, Inc., who explored its therapeutic potential for major depressive disorder (MDD) and…